EL MUNDO on MSN
The Chinese drug developed against COVID that could become the key weapon against the Nipah virus
China now points out that VV116, a drug originally authorized for the treatment of Covid, has shown in laboratory tests a ...
The virus has a fatality rate ranging from 40 per cent to 75 per cent, according to health experts. There is currently no ...
Chinese researchers have demonstrated that the oral nucleoside drug VV116, which is already approved for treating Covid-19 in ...
As the Nipah cases in India raise worries across Asia, a new study by Chinese researchers has claimed that an existing oral ...
Nipah Virus Outbreak: Chinese researchers claim COVID-19 drug can fight the deadly infection - All you need to know ...
A Chinese journalist jailed for four years after documenting the early phases of the COVID-19 outbreak from the pandemic’s epicenter was sentenced on Friday to four more years in prison, Reporters ...
A joint research by Chinese scientists has recently found that the oral nucleoside drug VV116, approved for the treatment of ...
Sept. 22 (UPI) --A Chinese court has handed COVID-19 whistleblower Zhang Zhan an another four-year prison sentence, according to the United Nations. Zhang, 42, a former lawyer-turned-Chinese citizen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results